Copyright 2005 Elsevier B.V., All rights reserved.Modified cell-wall peptides have been rationally designed and studied in a semi-quantitative approach to factorising free energy contributions in binding to vancomycin-group antibiotics in aqueous solution. Binding energies for succinyl and fumaryl-D-Ala dipeptides. and N-oxalyl-γ-aminobutyric acid analogues, are compared with binding energies for the natural substrate N-Ac-D-Ala-D-Ala, and the truncated mono-peptide N-Ac-D-Ala. We estimate the binding energy of the N-terminal carboxyl group, by four independent analyses, to he -(14 to 17)±7 kJ mol-1 when differences in ligand binding energies are corrected for differences in contributions from the “cost” of restricting rotations and “benefi...
The factors that give rise to binding enhancements when a strongly dimerizing vancomycin-group antib...
Glycopeptide antibiotics, such as vancomycin and teicoplanin, are used to treat life-threatening inf...
The mode of action of a semisynthetic glycopeptide active against vancomycin-resistant bacteria has ...
Copyright 2004 Elsevier B.V., All rights reserved.The adverse cost in free energy of restricting an ...
AbstractMolecular dynamics simulations and free energy calculations have been used to examine in det...
AbstractBackground: The vancomycin group of glycopeptide antibiotics is active against a wide range ...
AbstractBackground: Vancomycin and related glycopeptide antibiotics exert their antimicrobial effect...
AbstractBackground Vancomycin and other related glycopeptide antibiotics are clinically very importa...
Background: The emergence of bacteria that are resistant to vancomycin (V), a glyeopeptide antibioti...
With rising disease rates and decreasing effectiveness of conventional antibiotics, there is an imme...
BackgroundThe emergence of bacteria that are resistant to vancomycin (V), a glycopeptide antibiotic,...
Peptides terminating in -Lys-D-Ala-D-Ala, -Lys-D-Ala-L-Ala and -Lys-D-Ala-D-Lactate were covalently ...
Antimicrobial peptides (AMPs) are a promising alternative to antibiotics for mitigating bacterial in...
Charles University in Prague Faculty of Pharmacy in Hradec Králové Department of Biochemical Science...
<div><p>Antimicrobial peptides (AMPs), produced by a wide range of organisms, have attracted attenti...
The factors that give rise to binding enhancements when a strongly dimerizing vancomycin-group antib...
Glycopeptide antibiotics, such as vancomycin and teicoplanin, are used to treat life-threatening inf...
The mode of action of a semisynthetic glycopeptide active against vancomycin-resistant bacteria has ...
Copyright 2004 Elsevier B.V., All rights reserved.The adverse cost in free energy of restricting an ...
AbstractMolecular dynamics simulations and free energy calculations have been used to examine in det...
AbstractBackground: The vancomycin group of glycopeptide antibiotics is active against a wide range ...
AbstractBackground: Vancomycin and related glycopeptide antibiotics exert their antimicrobial effect...
AbstractBackground Vancomycin and other related glycopeptide antibiotics are clinically very importa...
Background: The emergence of bacteria that are resistant to vancomycin (V), a glyeopeptide antibioti...
With rising disease rates and decreasing effectiveness of conventional antibiotics, there is an imme...
BackgroundThe emergence of bacteria that are resistant to vancomycin (V), a glycopeptide antibiotic,...
Peptides terminating in -Lys-D-Ala-D-Ala, -Lys-D-Ala-L-Ala and -Lys-D-Ala-D-Lactate were covalently ...
Antimicrobial peptides (AMPs) are a promising alternative to antibiotics for mitigating bacterial in...
Charles University in Prague Faculty of Pharmacy in Hradec Králové Department of Biochemical Science...
<div><p>Antimicrobial peptides (AMPs), produced by a wide range of organisms, have attracted attenti...
The factors that give rise to binding enhancements when a strongly dimerizing vancomycin-group antib...
Glycopeptide antibiotics, such as vancomycin and teicoplanin, are used to treat life-threatening inf...
The mode of action of a semisynthetic glycopeptide active against vancomycin-resistant bacteria has ...